Literature DB >> 35129196

Endoplasmic reticulum-mitochondria signaling in neurons and neurodegenerative diseases.

Andrea Markovinovic1, Jenny Greig1,2, Sandra María Martín-Guerrero1, Shaakir Salam1, Sebastien Paillusson1,3.   

Abstract

Recent advances have revealed common pathological changes in neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis with related frontotemporal dementia (ALS/FTD). Many of these changes can be linked to alterations in endoplasmic reticulum (ER)-mitochondria signaling, including dysregulation of Ca2+ signaling, autophagy, lipid metabolism, ATP production, axonal transport, ER stress responses and synaptic dysfunction. ER-mitochondria signaling involves specialized regions of ER, called mitochondria-associated membranes (MAMs). Owing to their role in neurodegenerative processes, MAMs have gained attention as they appear to be associated with all the major neurodegenerative diseases. Furthermore, their specific role within neuronal maintenance is being revealed as mutant genes linked to major neurodegenerative diseases have been associated with damage to these specialized contacts. Several studies have now demonstrated that these specialized contacts regulate neuronal health and synaptic transmission, and that MAMs are damaged in patients with neurodegenerative diseases. This Review will focus on the role of MAMs and ER-mitochondria signaling within neurons and how damage of the ER-mitochondria axis leads to a disruption of vital processes causing eventual neurodegeneration.
© 2022. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Endoplasmic reticulum; MAMs; Mitochondria; Neurodegenerative diseases; Neurons; Tethers

Mesh:

Year:  2022        PMID: 35129196     DOI: 10.1242/jcs.248534

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.235


  7 in total

Review 1.  Targeting ER-Mitochondria Signaling as a Therapeutic Target for Frontotemporal Dementia and Related Amyotrophic Lateral Sclerosis.

Authors:  Sandra M Martín-Guerrero; Andrea Markovinovic; Gábor M Mórotz; Shaakir Salam; Wendy Noble; Christopher C J Miller
Journal:  Front Cell Dev Biol       Date:  2022-05-27

Review 2.  Mitofusins: from mitochondria to fertility.

Authors:  Shanjiang Zhao; Nuo Heng; Huan Wang; Haoyu Wang; Haobo Zhang; Jianfei Gong; Zhihui Hu; Huabin Zhu
Journal:  Cell Mol Life Sci       Date:  2022-06-20       Impact factor: 9.207

3.  Workshop on RanBP2/Nup358 and acute necrotizing encephalopathy.

Authors:  Alexander F Palazzo; Jomon Joseph; Ming Lim; Kiran T Thakur
Journal:  Nucleus       Date:  2022-12       Impact factor: 4.590

4.  Endoplasmic reticulum stress and mitochondrial dysfunctions in metal-induced neurological pathology.

Authors:  Sophia Cai; Min Woo Kim; Pan Chen
Journal:  J Neurobiol Physiol       Date:  2022

5.  Disruption of the VAPB-PTPIP51 ER-mitochondria tethering proteins in post-mortem human amyotrophic lateral sclerosis.

Authors:  Naomi Hartopp; Dawn H W Lau; Sandra M Martin-Guerrero; Andrea Markovinovic; Gábor M Mórotz; Jenny Greig; Elizabeth B Glennon; Claire Troakes; Patricia Gomez-Suaga; Wendy Noble; Christopher C J Miller
Journal:  Front Cell Dev Biol       Date:  2022-08-16

6.  The PTPIP51 coiled-coil domain is important in VAPB binding, formation of ER-mitochondria contacts and IP3 receptor delivery of Ca2+ to mitochondria.

Authors:  Gábor M Mórotz; Sandra M Martín-Guerrero; Andrea Markovinovic; Sebastien Paillusson; Matthew R G Russell; Pedro M Pereira Machado; Roland A Fleck; Wendy Noble; Christopher C J Miller
Journal:  Front Cell Dev Biol       Date:  2022-08-31

Review 7.  TFEB; Beyond Its Role as an Autophagy and Lysosomes Regulator.

Authors:  Berenice Franco-Juárez; Cristina Coronel-Cruz; Beatriz Hernández-Ochoa; Saúl Gómez-Manzo; Noemi Cárdenas-Rodríguez; Roberto Arreguin-Espinosa; Cindy Bandala; Luis Miguel Canseco-Ávila; Daniel Ortega-Cuellar
Journal:  Cells       Date:  2022-10-07       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.